We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.47B
AUM Growth
-$18.2M
Cap. Flow
-$449M
Cap. Flow %
-30.59%
Top 10 Hldgs %
41.48%
Holding
78
New
15
Increased
6
Reduced
19
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 25.02%
2 Financials 13.74%
3 Energy 7.5%
4 Consumer Staples 1.67%
5 Materials 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC
26
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$14.4M 0.98%
1,358,303
WFC icon
27
Wells Fargo
WFC
$261B
$14.2M 0.97%
344,292
-75,000
-18% -$3.2M
TSM icon
28
PUT
TSMC
TSM
$2.09T
$12.9M 0.88%
+761,300
New +$13M
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$12.6B
$11M 0.75%
50,008
-19,449
-28% -$4.14M
ARMH
30
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$10.6M 0.72%
+220,100
New +$9.3M
ONIT
31
CALL
Onity Group
ONIT
$333M
$10.3M 0.7%
+12,333
New +$9.31M
STML
32
DELISTED
Stemline Therapeutics, Inc.
STML
$9.96M 0.68%
220,000
OLED icon
33
PUT
Universal Display
OLED
$3.71B
$9.61M 0.65%
300,000
ZX
34
DELISTED
China Zenix Auto Internatl Ltd
ZX
$9.29M 0.63%
3,147,200
+100,000
+3% +$293K
KERX
35
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$9.2M 0.63%
912,000
CASC
36
DELISTED
Cascadian Therapeutics, Inc.
CASC
$7.96M 0.54%
+643,683
New +$6.78M
RPRX
37
DELISTED
Repros Therapeutics Inc.
RPRX
$7.84M 0.53%
301,834
-938,754
-76% -$20.1M
ONIT
38
Onity Group
ONIT
$333M
$7.81M 0.53%
+9,333
New +$7.04M
DST
39
DELISTED
DST Systems Inc.
DST
$7.68M 0.52%
203,766
-743,800
-78% -$26.8M
RIG icon
40
Transocean
RIG
$5.92B
$7.34M 0.5%
165,043
-331,300
-67% -$15.7M
OPTR
41
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$7.27M 0.5%
577,566
-1,052,234
-65% -$13.9M
PSMI
42
DELISTED
PEREGRINE SEMICONDUCTOR CORP COM STK (DE)
PSMI
$7.18M 0.49%
800,000
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.79M 0.46%
+592,978
New +$5.83M
NBIX icon
44
Neurocrine Biosciences
NBIX
$17.7B
$6.11M 0.42%
+540,000
New +$7.42M
HLSS
45
PUT
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$5.2M 0.35%
236,200
+158,300
+203% +$3.75M
EPZM
46
DELISTED
Epizyme, Inc
EPZM
$5M 0.34%
125,000
ACHV icon
47
Achieve Life Sciences
ACHV
$626M
$3.71M 0.25%
182
ASPS icon
48
PUT
Altisource Portfolio Solutions
ASPS
$65.4M
$3.5M 0.24%
+3,125
New +$3.04M
VSTM icon
49
Verastem
VSTM
$532M
$3.38M 0.23%
22,592
QLTI
50
DELISTED
QLT Inc
QLTI
$2.89M 0.2%
625,000

Similar funds

QVT Financial's Q3 2013 Portfolio in Review

As of Q3 2013, QVT Financial held 78 positions worth $1.47B, down 1.2% from $1.49B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

QVT Financial withdrew a net $449M in Q3 2013, closing 5 positions and reducing 19 holdings. Its most notable exit was Tesla, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Financials and Energy.

Against the trend, QVT Financial opened a new position in PHH Corporation worth $21.8M.

  • QVT Financial's largest Q3 2013 buy was PHH Corporation: 919,355 shares worth $21.8M.
  • QVT Financial added most to DYAX CORPORATION in Q3 2013, an estimated $7.36M increase.
  • QVT Financial's biggest Q3 2013 reduction was E*Trade Financial Corporation, cutting an estimated $41M.
  • QVT Financial fully exited Tesla in Q3 2013, selling an estimated $24.2M.
  • QVT Financial's ten largest holdings make up 41% of its $1.47B portfolio in Q3 2013.
  • QVT Financial opened 15 new positions and closed 5 in Q3 2013.
  • QVT Financial's portfolio value fell 1.2% quarter-over-quarter to $1.47B.

Based on QVT Financial's 13F filing for Q3 2013, filed 14 Nov 2013.